[1]
|
Flynn, W.T. (2012) The Judicious Use of Medically Important Antimicrobial Drugs in Food-Producing Animals. Center for Veterinary Medicine (HFV-1), Food and Drug Administration. US Department of Health and Human Services, 2012. http://www.fda.gov/downloads/animalveterinary/guidancecomplianceenforce-ment/guidanceforindustry/ucm216936.pdf
|
[2]
|
ABC (2013) Antibiotics 1928-2000: Millenium Bugs. http://www.abc.net.au/science/slab/antibiotics/history.htm
|
[3]
|
Clardy, J., Fischbach, M. and Currie, C. (2009) The natural history of antibiotics. Current Biology, 19, R437-R441. http://dx.doi.org/10.1016/j.cub.2009.04.001
|
[4]
|
CVM-MSU (2011) The golden age of antibacterials: Antimicrobial resistance learning site. Michigan State University, East Lansing. http://amrls.cvm.msu.edu/pharmacology/historical-perspectives/the-golden-age-of-antibacterials
|
[5]
|
Davies, J. (2013) Antibiotic discovery: Then and now. Issue: Antimicrobials. Microbiology-today. http://www.sgm.ac.uk/en/publications/microbiology-today/past-issues.cfm/publication/antimicrobials/article/C1FD8C70-FA3C-4829-8E8DC35E8BD2F470
|
[6]
|
VITEK (2008) Antibiotic classification and modes of action: Antibiotic classification. VITEK 2-Technology. © bio-Mérieux, Inc., Customer Education. http://www.biomerieux-usa.com/upload/VITEK-Bus-Module-1-Antibiotic-Classification-and-Modes-of-Action-1.pdf
|
[7]
|
Fischbach, M.A. and Walsh, C.T. (2009) Antibiotics for Emerging Pathogens. Science, 325, 1089-1093. http://dx.doi.org/10.1126/science.1176667
|
[8]
|
Glew, R. (2010) Bacterial resistance to antimicrobials: From the Golden Age to the Bronze Age of antibiotic use. Medical Center. http://veterinarymedicine.dvm360.com/vetmed/Medicine/Bacterial-resistance-to-antimicrobials-From-the-Go/ArticleStandard/Article/detail/660591
|
[9]
|
Gottfried, J. (2005) History repeating? Avoiding a Return to the Pre-Antibiotic Age. Harvard University’s DASH Repository, 1-72. http://dash.harvard.edu/bitstream/handle/1/8889467/Gottfried05.pdf?sequence=1
|
[10]
|
Brunton, L.L., Chabner, B.A. and Knollmann, B.C. (2013) Chemotherapy of microbial diseases: Goodman & gilman’s the pharmacological basis of therapeutics, 12e. McGraw-Hill Global Education Holdings, LLC, Section VII. http://accessmedicine.com/resourceTOC.aspx?resourceID=651
|
[11]
|
Labnotesweek4 (2013) Modes of action for antimicrobial Agents. http://lifesci.rutgers.edu/skelly/spring/labnotesweek4.htm
|
[12]
|
CVM-MSU (2011) Mechanisms of resistance against different antimicrobial classes: Microbiology. Michigan State University. http://amrls.cvm.msu.edu/microbiology/bacterial-resis-tance-strategies/introduction/tools/module-pdf-files/microbiology
|
[13]
|
Torrence, M.E., et al. (2008) Antibiotics: Mode of action, mechanisms of resistance, and transfer. Microbial food safety in animal agriculture: Current topics. John Wiley & Sons, Inc. http://dx.doi.org/10.1002/9780470752616.ch6
|
[14]
|
Wilcox, S. (2013) Cationic peptides: A new hope. The Science Creative Quarterly, 8. http://www.scq.ubc.ca/cationic-peptides-a-new-hope/
|
[15]
|
Esan, A. (2008) Ethical concerns regarding misleading drug promotion/marketing by the pharmaceutical industry. Journal and Proceedings of the Northern Ireland Ethics Forum, 5, 42-49. http://www.qub.ac.uk/methics/EsanA2008.pdf
|
[16]
|
Hogerzeil, H. and Reed, T. (2005) Understanding and responding to pharmaceutical promotion a practical guide first edition working draft for pilot field testing. World Health Organization/Health Action International Collaborative Project, 9-163. http://www.haiweb.org/11062009/drug-promotion-manual-CAP-3-090610.pdf
|
[17]
|
Norris, P., et al. (2005) Drug promotion: What we know, what we have yet to learn. Reviews of materials in the WHO/HAI database on drug promotion. World Health Organization and Health Action International 2005. http://www.who.int/medicines/areas/rational_use/drugPromodhai.pdf
|
[18]
|
PEW (2013) Persuading the prescribers: Pharmaceutical industry marketing and its influence on physicians and patients. Pew Charitable Trusts (PEW). http://www.pewhealth.org/other-resource/persuading-the-prescribers-pharmaceutical-industry-marketing-and-its-influence-on-physicians-and-patients-85899439814#sthash.6Ope0GFJ.dpuf
|
[19]
|
Sufrin, C.B. and Ross, J.S. (2008) Pharmaceutical industry marketing: Understanding its impact on women’s health. Obstetrical & Gynecological Survey, 63, 585-596. http://dx.doi.org/10.1097/OGX.0b013e31817f1585
|
[20]
|
Cegedim (2013) U.S. Pharmaceutical Company Promotion Spending. Cegedim Strategic Data 2012. http://www.skainfo.com/health_care_market_reports/2012_promotional_spending.pdf
|
[21]
|
Brand, R. (2008) Marketing drugs: Debating the real cost: Concern about close ties between doctors and pharmaceutical firms are prompting new financial disclosure laws and education efforts. State Legis, 34, 26-29.
|
[22]
|
Buckley, J. (2013) Pharmaceutical Marketing—Time for Change. Electronic Journal of Business Ethics and Organization Studies, 9, 4-11. http://ejbo.jyu.fi/pdf/ejbo_vol9_no2_pages_4-11.pdf
|
[23]
|
Neslin, S. (2011) ROI Analysis of Pharmaceutical Promotion (RAPP): An Independent Study. Pharmxpert. http://www.pharmxpert.net/web/board/b_ne01upload/RAPP%EC%A1%B0%EC%82%AC.pdf
|
[24]
|
Wazana, A. (2000) Physicians and the pharmaceutical industry: Is a gift ever just a gift? Journal of the American Medical Association, 283, 373-380. http://dx.doi.org/10.1001/jama.283.3.373
|
[25]
|
Alexander, C.G., Zhang, J. and Basu, A. (2008) Characteristics of patients receiving pharmaceutical samples and association between sample receipt and out-of-pocket prescription costs. Medical Care, 46, 394-402. http://dx.doi.org/10.1097/MLR.0b013e3181618ee0
|
[26]
|
Widayati, A., et al. (2011) Self medication with antibiotics in Yogyakarta City Indonesia: A cross sectional population-based survey. BMC Research Notes, 4, 491. http://dx.doi.org/10.1186/1756-0500-4-491
|
[27]
|
WHO (2011) Tackling antibiotic resistance from a food safety perspective in Europe. World Health Organization (WHO). http://www.euro.who.int/__data/assets/pdf_file/0005/136454/e94889.pdf
|
[28]
|
CDC (2010) National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS): Human Isolates Final Report, 2008. US Department of Health and Human Services, Atlanta, Georgia.
|
[29]
|
Meade-Callahan, M. (2001) Microbes: What they do & how antibiotics change them. American Institute of Biological Sciences. Actionbioscience.org. http://www.actionbioscience.org/evolution/meade_callahan.html
|
[30]
|
Baquero, F., Martinez, J. and Canton, R. (2008) Antibiotics and antibiotic resistance in water environments. Current Opinion in Biotechnology, 19, 260-265. http://dx.doi.org/10.1016/j.copbio.2008.05.006
|
[31]
|
Sukul, P. and Spiteller, M. (2007) Fluoroquinolone antibiotics in the environment. Reviews of Environmental Contamination and Toxicology, 191, 131-162. http://dx.doi.org/10.1007/978-0-387-69163-3_5
|
[32]
|
Ding, C. and He, J. (2010) Effect of antibiotics in the environment on microbial populations. Applied Microbiology & Biotechnology, 87, 925-941. http://dx.doi.org/10.1007/s00253-010-2649-5
|
[33]
|
Martinez, J.L. (2009) Environmental pollution by antibiotics and by antibiotic resistance determinants. Environmental Pollution, 157, 2893-2902. http://dx.doi.org/10.1016/j.envpol.2009.05.051
|
[34]
|
Biyela, P.T., J. Lin, and Bezuidenhout, C.C. (2004) The role of aquatic ecosystems as reservoirs of antibiotic resistant bacteria and antibiotic resistance genes. Water Science and Technology, 50, 45-50.
|
[35]
|
Giguère, S. (2006) Antimicrobial drug action and interaction: An introduction. In: Giguère, S., Prescott, J.F., Baggot, J.D., Walker, R.D. and Dowling, P.M., Eds., Antimicrobial therapy in Veterinary Medicine (4th ed.), Blackwell Publishing, Ames Iowa.
|
[36]
|
Kümmerer, K. (2003) Significance of antibiotics in the environment. Journal of Antimicrobial Chemotherapy, 52, 5-7. http://dx.doi.org/10.1093/jac/dkg293
|
[37]
|
Kümmerer, K. (2008) Effects of antibiotics and virustatics in the environment. Pharmaceuticals in the Environment, Springer, Berlin, 223-244.
|
[38]
|
Gaash, B. (2008) Irrational use of antibiotics. Indian Journal for the Practising Doctor, 5.
|
[39]
|
GARP (2011) Rationalizing antibiotic use to limit antibiotic resistance in India. Global Antibiotic Resistance Partnership (GARP)-India Working Group. Indian Journal of Medical Research, 134, 281-294. http://icmr.nic.in/ijmr/2011/september/0905.pdf
|
[40]
|
WHO (2002) Promoting rational use of medicines: Core components: WHO policy perspectives of medicines. No. 5. World Health Organization, Geneva.
|
[41]
|
Cabello, F.C. (2006) Heavy use of prophylactic antibiotics in aquaculture: A growing problem for human and animal health and for the environment. Environmental Microbiology, 8, 1137-1144. http://dx.doi.org/10.1111/j.1462-2920.2006.01054.x
|
[42]
|
Mehrotra, M., Dougherty, J. and Poppe, C. (2003) Antimicrobial resistance: Strengthening the policy research connection. Health Policy Research Bulletin, Canada. http://www.hc-sc.gc.ca/sr-sr/alt_formats/hpb-dgps/pdf/pubs/hpr-rps/bull/2003-6-antimicrob/2003-6-antimicrob-eng.pdf
|
[43]
|
Andersson, D. (2004) The ways in which bacteria resist antibiotics: The global threat of antibiotic resistance, exploring roads towards concerted action. A Multidisisciplinary Meeting at the DAG HAMMAR-SKJÖLD Foundation, Uppsala, 5-7 May 2004, Background Document. http://archives.who.int/prioritymeds/report/append/bacteria.pdf.
|
[44]
|
Berger-Bächi, B. (2002) Resistance mechanisms of Gram positive bacteria. International Journal of Medical Microbiology, 292, 27-35. http://dx.doi.org/10.1078/1438-4221-00185
|
[45]
|
Forbes, B.A., Sahm, D.F. and Weissfeld, A.S. (1998) Bailey and Scott’s diagnostic microbiology. 10th Edition, Mosby Inc., St. Louis Missouri.
|
[46]
|
Hawkey, P.M. (1998) The origins and molecular basis of antibiotic resistance. British Medical Journal, 317, 657-660. http://dx.doi.org/10.1136/bmj.317.7159.657
|
[47]
|
Promega (2013) Antibiotics: Mode of action and mechanism of resistance. Technical Reference, Promega Foundation. http://www.promega.com/~/media/Files/Resources/Technical%20References/Antibiotic%20Mode%20of%20Action.pdf.
|
[48]
|
Sosa, A., Byarugaba, D.K., Amabile, C., Hsueh, P.R., Kariuki, S. and Okeke, I.N. (2010) Antimicrobial resistance in developing countries. Microbiology. http://www.springer.com/978-0-387-89369-3
|
[49]
|
Tenover, F.C. (2006) Mechanisms of antimicrobial resistance in bacteria. The American Journal of Medicine, 119, S3-S10. http://dx.doi.org/10.1016/j.amjmed.2006.03.011
|
[50]
|
Alexander, T.W., Yanke, J.L., Reuter, T., Topp, E., Read, R.R., Selinger, B.L. and McAllister, T.A. (2011) Longitudinal characterization of antimicrobial resistance genes in feces shed from cattle fed different subtherapeutic antibiotics. BMC Microbiology, 11, 19. http://www.biomedcentral.com/1471-2180/11/19.
|
[51]
|
PEW. (2013) Antibiotic resistance and food animal production: A bibliography of scientific studies (1969-2012). The PEW Charitable Trust. http://www.pewhealth.org/uploadedFiles/PHG/Content_Level_Pages/Issue_Briefs/HHIFBibliographyFinal%20with%20TOC%20_111312.pdf
|
[52]
|
Salyers, A.A. and Amabile-Cuevas, C.F. (1997) Why are antibiotic resistance genes so resistant to elimination? Antimicrobial Agents and Chemotherapy, 41, 2321-2325.
|
[53]
|
Furuya, E.Y. and Lowy, F. (2006) Antimicrobial-resistant bacteria in the community setting. Nature Reviews Microbiology, 4, 36-45. http://dx.doi.org/10.1038/nrmicro1325
|
[54]
|
Encyclopædia-Britannica (2013) Antibiotic resistance: Mechanisms of antibiotic resistance. Encyclopædia Britannica Online. http://www.britannica.com/EBchecked/media/129670/There-are-multiple-mechanisms-by-which-bacteria-can-develop-resistance.
|
[55]
|
Todar, K. (2011) Bacterial mechanisms of antibiotic resistance. Todar’s Online Textbook of Bacteriology, Madison. http://textbookofbacteriology.net/resantimicrobial_3.html
|
[56]
|
FASS (2010) Preserving the benefits of antibiotics for people and animals policy. Federation of Animal Science Societies (FASS). http://www.fass.org/PreservingBenefitsAntibiotics.pdf
|
[57]
|
Holloway, K.A. (2011) Promoting the rational use of antibiotics. Regional Adviser, Essential drugs and other medicines, World Health Organization, Regional Office for South-East Asia. Regional Health, 15, 122-130.
|
[58]
|
WHO (2007) Progress in the rational use of medicines. World Health Assembly Resolution. Document No. WHA60.16. World Health Organization, Geneva, WHO, 71. http://apps.who.int/gb/ebwha/pdf_files/WHASSA_WHA60-Rec1/E/reso-60-en.pdf
|
[59]
|
APUA (2012) The need to improve antibiotic use in food animals. The Alliance for the Prudent Use of Antibiotics (APUA). http://www.tufts.edu/med/apua/consumers/personal_home_25_277960095.pdf
|
[60]
|
WHO (2006) The role of education in the rational use of medicines. World Health Organisation, Geneva. SEARO Technical Publication Series No. 45, 2006.
|
[61]
|
WHO (2009) Medicines use in primary care in developing and transitional countries: Fact book summarizing results from studies reported between 1990 and 2006. Document No WHO/EMP/MAR/2009.3. World Health Organization, Geneva, WHO, 2009.
|
[62]
|
Abdulah, R. (2012) Antibiotic abuse in developing Countries. Pharmaceutical Regulatory Affairs, 1, e106. http://dx.doi.org/10.4172/2167-7689.1000e106
|
[63]
|
Amin, N. (2011) Use and misuse of antibiotics. Ibrahim Cardiac Medical Journal, 1, 7-9.
|
[64]
|
Askarian, M. and Maharlouie, N. (2012) Irrational antibiotic use among secondary school teachers and university faculty members in Shiraz, Iran. International Journal of Preventive Medicine, 3, 839-845. http://dx.doi.org/10.4103/2008-7802.104854
|
[65]
|
Chandy, S.J. (2008) Consequences of irrational use of antibiotics. Journal of the Forum for Medical Ethics Society, V.
|
[66]
|
Elsiddi, H.A.A., Badr, E. and Abuzaid, A. (2010) Irrational use of antibiotics among people residing in Almamoura. Sudanese Journal of Public Health, 5, 50-55.
|
[67]
|
Planta, M.B. (2007) The role of poverty in antimicrobial resistance. Journal of the American Board of Family Medicine, 20, 533-539. http://dx.doi.org/10.3122/jabfm.2007.06.070019
|